BCBA/CTIOD (BCBA/CTIOD)

Buenos Aires Stock Exchange: BCBA/CTIOD · USD

$1.51

+0.00 (0.0%)· Recorded snapshot

Market cap	686.6B
Revenue (ttm)	334.6B
Net income (ttm)	-31.5B
EPS (ttm)	-$76.7
Dividend	$53.6 (2.31%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 334.6B
Net income (ttm): -31.5B
EPS (ttm): -$76.7
Market cap: 686.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-4.6

P25 n/aP50 n/aP75 n/a

ROIC-1.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.5%

Nasdaq Composite-2.4%

Dow Jones Industrial Average+1.8%

Russell 2000+1.8%

All BCBA/CTIOD indicators

Market & fundamental data

Available fields

143

Groups with data

Currency

ARS

Showing 143 of 143 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Argentina
Country code	AR
Earnings date	2026-11-11
Enterprise value	$588B
Exchange	Buenos Aires Stock Exchange
Financial currency	ARS
Financial report date	2026-06-30
First seen	2026-09-21
Fiscal year end	December
Founded	1981
Industry	Real Estate - Development
Is primary listing	No
ISIN number	ARCTIO010019
Last refreshed	2026-10-28
Market cap	$686.6B
Next earnings date	2026-11-11
Price	$1.51
Price currency	USD
Sector	Real Estate
SIC code	6552
Stock price date	2026-10-06
Symbol	bcba/CTIOD
Website	https://www.consultatio.com.ar

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	17.97x
Earnings yield	-3.3%
EV/Sales	1.76x
FCF / EV yield	-8.55%
FCF yield	-7.32%
P/B ratio	0.69x
P/S ratio	2.05x
Price / tangible book value	0.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-4.12%
EBITDA margin	-3.75%
Gross margin	15.23%
Operating margin	-4.12%
Pretax margin	-13.64%
Profit margin	-9.4%
ROA	-0.56%
ROA (5Y)	0.62%
ROCE	-0.96%
ROE	-4.56%
ROE (5Y)	4.58%
ROIC	-1.71%
ROIC (5Y)	-0.11%
Tax / revenue	-1.37%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-51.87%
Gross profit growth (Q)	71.44%
Gross profit growth 3Y	-2.56%
Gross profit growth 5Y	40.13%
Revenue growth	46.01%
Revenue growth (Q)	210.47%
Revenue growth (QoQ)	83.09%
Revenue growth 10Y	88.14%
Revenue growth 3Y	26.15%
Revenue growth 5Y	75.76%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$112M
Depreciation and amortization	$1.3B
EBIT	$-13.8B
EBITDA	$-12.5B
EPS	$-76.74
Financing cash flow	$-26.5B
Free cash flow	$-50.3B
Gross profit	$51B
Income taxes	$-4.6B
Investing cash flow	$10.6B
Net borrowing	$11.8B
Net cash flow	$-65.1B
Net income	$-31.5B
Operating income	$-13.8B
Revenue	$334.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.67
Book value per share	$2,303.55
Debt / equity	0.03
Interest coverage	-0.89
Long-term assets	$1.1T
Long-term liabilities	$454.8B
Net cash (debt)	$143.2B
Net cash / market cap	20.85%
Net cash growth	-4.6%
Net debt / equity	-0.14
Piotroski F-Score	2
Property, plant and equipment	$36.2B
Shareholders' equity	$988.8B
Tangible book value	$944.2B
Tangible book value per share	$2,303.55
Total assets	$1.6T
Total cash	$168.1B
Total debt	$24.9B
Total liabilities	$640.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.22
Current assets	$486.8B
Current liabilities	$185.8B
Current ratio	2.62
Inventory turnover	0.92
Net working capital	$157.9B
Quick ratio	0.98
Working capital	$301B
Working capital turnover	1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.01%
Dividend growth	-38.28%
Dividend growth (3Y)	547.62%
Dividend growth years	1
Dividend payment date	2026-05-08
Dividend payment years	6
Dividend payout frequency	Annual
Dividend per share	$53.60
Dividend yield	2.31%
Ex-dividend date	2026-05-07
Last dividend	$0.04
Shareholder yield	2.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1W price change	-4.73%
1W total return	-4.73%
52-week high	$1.59
52-week high date	2026-09-18
52-week low	$1.51
52-week low date	2026-10-06
All-time high	$1.59
All-time high date	2026-09-18
All-time low	$1.51
All-time low date	2026-10-02
Average volume	0
Change from 52-week high	-4.73%
Change from 52-week low	0%
Change from all-time high	-4.73%
Change from all-time low	0%
Change from open	0%
Day's gap	0%
High price	$1.51
Low price	$1.51
Monthly RSI	0
Open price	$1.51
Previous close	$1.51
RSI	0
Sharpe ratio	-10.78
Sortino ratio	-8.86
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12.3M
Shares change (QoQ)	0%
Shares change (YoY)	-0.01%
Shares held by insiders	72%
Shares held by institutions	25%

Deeper analysis on BCBA/CTIOD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BCBA/CTIOD report

Is a complete BCBA/CTIOD research report available?

No complete published report is available for bcba/CTIOD (BCBA/CTIOD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

686.6B

Revenue (ttm)

334.6B

Net income (ttm)

-31.5B

EPS (ttm)

-$76.7

Dividend

$53.6 (2.31%)

Metric

Value

Amount currency

ARS

Country

Argentina

Country code

Earnings date

2026-11-11

Enterprise value

$588B

Exchange

Buenos Aires Stock Exchange

Financial currency

ARS

Financial report date

2026-06-30

First seen

2026-09-21

Fiscal year end

December

Founded

1981

Industry

Real Estate - Development

Is primary listing

ISIN number

ARCTIO010019

Last refreshed

2026-10-28

Market cap

$686.6B

Next earnings date

2026-11-11

Price

$1.51

Price currency

USD

Sector

Real Estate

SIC code

6552

Stock price date

2026-10-06

Symbol

bcba/CTIOD

Website

https://www.consultatio.com.ar

Metric

Value

Average P/E ratio (10Y)

17.97x

Earnings yield

-3.3%

EV/Sales

1.76x

FCF / EV yield

-8.55%

FCF yield

-7.32%

P/B ratio

0.69x

P/S ratio

2.05x

Price / tangible book value

0.73x

Metric

Value

EBIT margin

-4.12%

EBITDA margin

-3.75%

Gross margin

15.23%

Operating margin

-4.12%

Pretax margin

-13.64%

Profit margin

-9.4%

ROA

-0.56%

ROA (5Y)

0.62%

ROCE

-0.96%

ROE

-4.56%

ROE (5Y)

4.58%

ROIC

-1.71%

ROIC (5Y)

-0.11%

Tax / revenue

-1.37%

Metric

Value

Gross profit growth

-51.87%

Gross profit growth (Q)

71.44%

Gross profit growth 3Y

-2.56%

Gross profit growth 5Y

40.13%

Revenue growth

46.01%

Revenue growth (Q)

210.47%

Revenue growth (QoQ)

83.09%

Revenue growth 10Y

88.14%

Revenue growth 3Y

26.15%

Revenue growth 5Y

75.76%

Metric

Value

Capital expenditures

$112M

Depreciation and amortization

$1.3B

EBIT

$-13.8B

EBITDA

$-12.5B

EPS

$-76.74

Financing cash flow

$-26.5B

Free cash flow

$-50.3B

Gross profit

$51B

Income taxes

$-4.6B

Investing cash flow

$10.6B

Net borrowing

$11.8B

Net cash flow

$-65.1B

Net income

$-31.5B

Operating income

$-13.8B

Revenue

$334.6B

Metric

Value

Altman Z-Score

1.67

Book value per share

$2,303.55

Debt / equity

0.03

Interest coverage

-0.89

Long-term assets

$1.1T

Long-term liabilities

$454.8B

Net cash (debt)

$143.2B

Net cash / market cap

20.85%

Net cash growth

-4.6%

Net debt / equity

-0.14

Piotroski F-Score

Property, plant and equipment

$36.2B

Shareholders' equity

$988.8B

Tangible book value

$944.2B

Tangible book value per share

$2,303.55

Total assets

$1.6T

Total cash

$168.1B

Total debt

$24.9B

Total liabilities

$640.6B

Metric

Value

Asset turnover

0.22

Current assets

$486.8B

Current liabilities

$185.8B

Current ratio

2.62

Inventory turnover

0.92

Net working capital

$157.9B

Quick ratio

0.98

Working capital

$301B

Working capital turnover

1.22

Metric

Value

Buyback yield / dilution

0.01%

Dividend growth

-38.28%

Dividend growth (3Y)

547.62%

Dividend growth years

Dividend payment date

2026-05-08

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

$53.60

Dividend yield

2.31%

Ex-dividend date

2026-05-07

Last dividend

$0.04

Shareholder yield

2.32%

Metric

Value

1D price change

1W price change

-4.73%

1W total return

-4.73%

52-week high

$1.59

52-week high date

2026-09-18

52-week low

$1.51

52-week low date

2026-10-06

All-time high

$1.59

All-time high date

2026-09-18

All-time low

$1.51

All-time low date

2026-10-02

Average volume

Change from 52-week high

-4.73%

Change from 52-week low

Change from all-time high

-4.73%

Change from all-time low

Change from open

Day's gap

High price

$1.51

Low price

$1.51

Monthly RSI

Open price

$1.51

Previous close

$1.51

RSI

Sharpe ratio

-10.78

Sortino ratio

-8.86

Weekly RSI

Metric

Value

Float

12.3M

Shares change (QoQ)

Shares change (YoY)

-0.01%

Shares held by insiders

72%

Shares held by institutions

25%

BCBA/CTIOD (BCBA/CTIOD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/CTIOD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/CTIOD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/CTIOD

Frequently asked questions

BCBA/CTIOD (BCBA/CTIOD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/CTIOD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/CTIOD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/CTIOD

Frequently asked questions